ADAERATA LTD PARTNERSHIP has a total of 15 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Canada, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are INNOVENT BIOLOGICS SUZHOU CO LTD, BIOSCEPTRE INTERNATIONAL LTD and I MAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | Hong Kong | 2 | |
#6 | Republic of Korea | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Seidah Nabil G | 9 |
#2 | Guay Daniel | 7 |
#3 | Skorey Kathryn | 7 |
#4 | Lachance Nicolas | 7 |
#5 | Crane Sheldon | 7 |
#6 | Truong Vouy Linh | 7 |
#7 | Lacombe Patrick | 7 |
#8 | Tremblay Michel | 3 |
#9 | Zhang Jianbing | 3 |
#10 | Seidah Nabil | 3 |
Publication | Filing date | Title |
---|---|---|
WO2016172795A1 | Modulating uracil-dna glycosylase and uses thereof | |
EP2961765A1 | Small molecule modulators of pcsk9 and methods of use thereof | |
CN104169304A | Single domain antibodies as inhibitors of PCSK9 |